New Uses for Old Copper-binding Drugs: Converting the Pro-angiogenic Copper to a Specific Cancer Cell Death Inducer

Overview

Journal Expert Opin Ther Targets

Publisher Informa Healthcare

Specialty Pharmacology

Date 2008 May 16

PMID 18479220

Citations 25

Authors

Di Chen

Q Ping Dou

Affiliations

Soon will be listed here.

Abstract

Background: The conventional approach toward anticancer drug development is a time-consuming and expensive procedure.

Objective/methods: One approach to expedite this process and achieve more affordable means is to discover new applications of existing drugs, since their pharmacokinetics and pharmacological profiles are well known.

Results: Our encouraging findings in recent studies reveal anticancer activities of several copper-binding ligands including disulfiram (an antialcoholism drug), clioquinol (used to treat Alzheimer's and Huntington's diseases) and diethyldithiocarbamate (an agent for HIV-1 infection treatment).

Conclusion: These in vitro and in vivo studies have demonstrated that these archaic drugs can target and react with tumor cellular copper, forming complexes that act as potent proteasome inhibitors and apoptosis inducers.

Citing Articles

The Effects of Different Treatments on Serum Trace Element Levels in Dogs with Heart Failure.

Bilgic B, Tarhan D, Or M Animals (Basel). 2024; 14(23).

PMID: 39682356 PMC: 11639861. DOI: 10.3390/ani14233390.

LIFU/MMP-2 dual-responsive release of repurposed drug disulfiram from nanodroplets for inhibiting vasculogenic mimicry and lung metastasis in triple-negative breast cancer.

Liu Y, Tang R, Cao Y, Wu N, Qin Q, Chen Y J Nanobiotechnology. 2024; 22(1):209.

PMID: 38664830 PMC: 11046851. DOI: 10.1186/s12951-024-02492-7.

Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems.

Kang X, Jadhav S, Annaji M, Huang C, Amin R, Shen J Pharmaceutics. 2023; 15(6).

PMID: 37376016 PMC: 10302862. DOI: 10.3390/pharmaceutics15061567.

Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways.

Gan Y, Liu T, Feng W, Wang L, Li L, Ning Y Oncol Res. 2023; 31(3):333-343.

PMID: 37305383 PMC: 10229305. DOI: 10.32604/or.2023.028694.

Disulfiram Enhances the Antineoplastic Activity and Sensitivity of Murine Hepatocellular Carcinoma to 5-FU via Redox Management.

Hassan I, Ebaid H, Alhazza I, Al-Tamimi J, Rady A Pharmaceuticals (Basel). 2023; 16(2).

PMID: 37259318 PMC: 9967644. DOI: 10.3390/ph16020169.

References

Orlowski R, Voorhees P, Garcia R, Hall M, Kudrik F, Allred T . Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies. Blood. 2005; 105(8):3058-65. DOI: 10.1182/blood-2004-07-2911. View

Pang H, Chen D, Cui Q, Dou Q . Sodium diethyldithiocarbamate, an AIDS progression inhibitor and a copper-binding compound, has proteasome-inhibitory and apoptosis-inducing activities in cancer cells. Int J Mol Med. 2007; 19(5):809-16. View

Gullino P . Considerations on the mechanism of the angiogenic response. Anticancer Res. 1986; 6(2):153-8. View

Veeravagu A, Hsu A, Cai W, Hou L, Tse V, Chen X . Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy. Recent Pat Anticancer Drug Discov. 2008; 2(1):59-71. DOI: 10.2174/157489207779561426. View

Eatock M, Schatzlein A, Kaye S . Tumour vasculature as a target for anticancer therapy. Cancer Treat Rev. 2000; 26(3):191-204. DOI: 10.1053/ctrv.1999.0158. View

Ryan C, Wilding G . Angiogenesis inhibitors. New agents in cancer therapy. Drugs Aging. 2000; 17(4):249-55. DOI: 10.2165/00002512-200017040-00001. View

Nasulewicz A, Mazur A, Opolski A . Role of copper in tumour angiogenesis--clinical implications. J Trace Elem Med Biol. 2004; 18(1):1-8. DOI: 10.1016/j.jtemb.2004.02.004. View

Groll M, Bajorek M, Kohler A, Moroder L, Rubin D, Huber R . A gated channel into the proteasome core particle. Nat Struct Biol. 2000; 7(11):1062-7. DOI: 10.1038/80992. View

Brewer G . Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's disease. Exp Biol Med (Maywood). 2001; 226(7):665-73. DOI: 10.1177/153537020222600712. View

10.

Yoshii J, Yoshiji H, Kuriyama S, Ikenaka Y, Noguchi R, Okuda H . The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells. Int J Cancer. 2001; 94(6):768-73. DOI: 10.1002/ijc.1537. View

11.

Brar S, Grigg C, Wilson K, Holder Jr W, Dreau D, Austin C . Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner in vitro, in mice and in a patient with metastatic disease. Mol Cancer Ther. 2004; 3(9):1049-60. View

12.

Teicher B, Ara G, Herbst R, Palombella V, Adams J . The proteasome inhibitor PS-341 in cancer therapy. Clin Cancer Res. 1999; 5(9):2638-45. View

13.

Folkman J . Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg. 1972; 175(3):409-16. PMC: 1355186. DOI: 10.1097/00000658-197203000-00014. View

14.

KAPLAN C, Petersen E, Yocum D, Hersh E . A randomized, controlled dose response study of intravenous sodium diethyldithiocarbamate in patients with advanced human immunodeficiency virus infection. Life Sci. 1989; 45(22):iii-ix. DOI: 10.1016/0024-3205(89)90070-2. View

15.

Ritchie C, Bush A, Masters C . Metal-protein attenuating compounds and Alzheimer's disease. Expert Opin Investig Drugs. 2004; 13(12):1585-92. DOI: 10.1517/13543784.13.12.1585. View

16.

Lowndes S, Harris A . The role of copper in tumour angiogenesis. J Mammary Gland Biol Neoplasia. 2006; 10(4):299-310. DOI: 10.1007/s10911-006-9003-7. View

17.

Fox S, Gasparini G, Harris A . Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs. Lancet Oncol. 2002; 2(5):278-89. DOI: 10.1016/S1470-2045(00)00323-5. View

18.

Culotta V, Klomp L, Strain J, Casareno R, Krems B, Gitlin J . The copper chaperone for superoxide dismutase. J Biol Chem. 1997; 272(38):23469-72. DOI: 10.1074/jbc.272.38.23469. View

19.

Ohgami R, Campagna D, McDonald A, Fleming M . The Steap proteins are metalloreductases. Blood. 2006; 108(4):1388-94. PMC: 1785011. DOI: 10.1182/blood-2006-02-003681. View

20.

Reisinger E, Kern P, Ernst M, Bock P, Flad H, Dietrich M . Inhibition of HIV progression by dithiocarb. German DTC Study Group. Lancet. 1990; 335(8691):679-82. DOI: 10.1016/0140-6736(90)90802-c. View